Of note, the Q26X homozygous child was diagnosed with PAH at 3 years of age and telangiectasias at 10 years, but BMP9 and BMP10 levels were only measured at 10 years (Hodgson et al., 2021; Wang et al., 2016). Here, BMP10 is linked to pulmonary arterial hypertension.